NVIV
InVivo Therapeutics Holdings Corp
NVIV
NVIV
Delisted
NVIV was delisted on the 12th of February, 2024.
16 hedge funds and large institutions have $1.32M invested in InVivo Therapeutics Holdings Corp in 2021 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 3 increasing their positions, 4 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less capital invested
Capital invested by funds: $ → $
less first-time investments, than exits
New positions opened: | Existing positions closed:
Holders
16
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$29K | |
| 2 | +$11.7K | |
| 3 | +$7.22K | |
| 4 |
ICM
IMS Capital Management
Portland,
Oregon
|
+$6.6K |
| 5 |
Millennium Management
New York
|
+$6.37K |
Top Sellers
| 1 | -$394K | |
| 2 | -$33K | |
| 3 | -$30K | |
| 4 |
Morgan Stanley
New York
|
-$14.5K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$2.49K |